Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Maternal Blood Biomarkers Identify Risk of Preterm and Early-Term Birth

By LabMedica International staff writers
Posted on 18 Jun 2026

Preterm and early-term births can lead to lasting complications because vital organs continue to mature during the final weeks of pregnancy. More...

Babies born too soon face increased risks of breathing difficulties, hearing loss, and vision problems, yet clinicians still lack reliable early indicators to distinguish spontaneous from medically indicated early delivery. A new study identifies distinct metabolomic signatures in maternal blood associated with both the timing and type of early birth.

At Emory University’s Rollins School of Public Health (Atlanta, GA, USA), investigators analyzed blood samples from pregnant African American women in Atlanta to compare metabolomic profiles between pregnancies that ended early and those that reached full term. The study aimed to identify molecular differences, or metabolomic signatures, detectable as early as the first trimester. The team also assessed whether these profiles varied between spontaneous early births and deliveries prompted by medical concerns affecting the mother or baby.

The analysis identified molecular signals in maternal blood that may help explain whether a pregnancy is more likely to end preterm, early term, or reach full term. Patterns associated with spontaneous early births frequently involved amino acids, which support fetal growth, placental function, and stress responses. In contrast, early deliveries prompted by medical indications were characterized by signatures linked to lipid energy metabolism and markers of cardiac and metabolic stress.

Findings from the study, “Maternal metabolomic signatures for risk of preterm and early term birth in African American women,” were published in Nature Health on June 16, 2026. According to the authors, the results provide biological clues that may enhance understanding of early birth mechanisms and, in the future, could inform the development of improved tools to identify higher-risk pregnancies. The work underscores that preterm and early-term births do not reflect a single pathway and may require distinct analytic considerations.

“Preterm and early-term births are not one single condition with one single cause. Our study shows that different types of early birth carry distinct molecular fingerprints during pregnancy. These findings may help us better understand the biology of early birth and, eventually, develop better tools to identify risk earlier and guide prevention strategies,” said Donghai Liang, PhD, associate professor of environmental health at Rollins and the study’s lead author.

Related Links
Emory University’s Rollins School of Public Health


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
MR-proADM Test
B•R•A•H•M•S MR-proADM KRYPTOR test
Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: A new study links broad genomic sequencing before first-line therapy to longer survival, supporting its role in treatment decisions (Image Credit: Shutterstock)

Study Supports Broad Genomic Profiling Before First-Line Lung Cancer Treatment

Biomarker testing plays a critical role in advanced non-small cell lung cancer by identifying patients who may benefit from targeted therapies. However, testing only one or two genes can miss actionable... Read more

Immunology

view channel
Image: The findings underscore the importance of aligning allergy testing with clinical history and diagnostic guidelines to reduce inappropriate testing and its consequences (Image Credit: iStock)

Survey Finds Gap Between Food Allergy Testing Awareness and Clinical Practice

Food allergy evaluation can be challenging when laboratory results do not match clinical symptoms. Broad food allergy panels may detect sensitization without confirming an actual allergy, potentially leading... Read more

Industry

view channel
Image Credit: iStock

C2N Makes PrecivityAD2 Alzheimer’s Blood Test Available to Clinicians

Diagnosing Alzheimer’s disease can be challenging, particularly in patients with mild cognitive impairment or early dementia. Assessing brain amyloid pathology can guide clinical decisions, but diagnostic... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.